IV Steroids in GCA: No Visual Benefit, Higher Diabetes Risk

This post was originally published on Medscape

You will shortly be re-directed to the publisher's website

Intravenous methylprednisolone is not significantly beneficial vs oral glucocorticoids in improving visual acuity or survival in patients with giant cell arteritis, and it increases diabetes risk.
Medscape Medical News